Fighting biofilms with lantibiotics and other groups of bacteriocins

npj Biofilms and Microbiomes

Volumn 4, Issue 1, 2018, Pages

  Mathur, Harsh ^a,b   Field, Des ^b,c   Rea, Mary C ^a,b   Cotter, Paul D ^a,b   Hill, Colin ^b,c   Ross, R Paul ^b,c  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; CINNAMALDEHYDE; CIPROFLOXACIN; CITRIC ACID; DAPTOMYCIN; GALLIDERMIN; HYPOCHLORITE SODIUM; ISK 1; LACTICIN Q; LANTIBIOTIC; LYSOZYME; NISIN; NUKACIN; POLYMYXIN; UNCLASSIFIED DRUG;

ACTINOMYCES VISCOSUS; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL CLEARANCE; BIOFILM; GARDNERELLA VAGINALIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUTH CAVITY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS MUTANS; TOOTH PLAQUE;

EID: 85045917461     PISSN: None     EISSN: 20555008     Source Type: Journal    
DOI: 10.1038/s41522-018-0053-6     Document Type: Article

References (176)

1. Flemming, H. C. et al. Biofilms: An emergent form of bacterial life. Nat. Rev. Microbiol. 14, 563-575 (2016).
2. Donlan, R. Biofilms: microbial life on surfaces. Emerg. Infect. Dis. 8, 881-890 (2002).
3. Olszewska, M. Microscopic findings for the study of biofilms in food environments. Acta Biochim. Pol. 60, 531-537 (2013).
4. Colagiorgi, A., Ciccio, P., Zanardi, E., Ghidini, S. & Ianieri, A. A look inside the Listeria monocytogenes biofilms extracellular matrix. Microorganisms 4, 22 (2016).
5. Kostakioti, M., Hadjifrangiskou, M. & Hultgren, S. J. Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb. Perspect. Med. 3, a010306 (2013).
6. Garrett, T. G., Bhakoo, M. & Zhang, Z. Bacterial adhesion and biofilms on surfaces. Prog. Nat. Sci. 18, 1049-1056 (2008).
7. Flemming, H. C. & Wingender, J. The biofilm matrix. Nat. Rev. Microbiol. 8, 623-633 (2010).
8. Høiby, N., Ciofu, O. & Bjarnsholt, T. Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol. 5, 1663-1674 (2010).
9. Smith, A. W. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv. Drug. Deliv. Rev. 57, 1539-1550 (2005).
10. Simões, M., Simões, L. C. & Vieira, M. J. A review of current and emergent biofilm control strategies. LWT Food Sci. Technol. 43, 573-583 (2010).
11. Dosler, S. & Karaaslan, E. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides. Peptides 62, 32-37 (2014).
12. Mataraci, E. & Dosler, S. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrob. Agents Chemother. 56, 6366-6371 (2012).
13. Algburi, A., Comito, N., Kashtanov, D., Dicks, L. M. & Chikindas, M. L. Control of biofilm formation: Antibiotics and beyond. Appl. Environ. Microbiol. 83, e02508-e02516 (2017).
14. Cotter, P. D., Ross, R. P. & Hill, C. Bacteriocins-A viable alternative to antibiotics? Nat. Rev. Microbiol. 11, 95-105 (2013).
15. Cotter, P. D., Hill, C. & Ross, R. P. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3, 777-788 (2005).
16. Chatterjee, C., Paul, M., Xie, L. & van der Donk, W. A. Biosynthesis and mode of action of lantibiotics. Chem. Rev. 105, 633-684 (2005).
17. Bierbaum, G. & Sahl, H. G. Lantibiotics: mode of action, biosynthesis and bioengineering. Curr. Pharm. Biotechnol. 10, 2-18 (2009).
18. Chikindas, M. L., Weeks, R., Drider, D., Chistyakov, V. A. & Dicks, L. M. Functions and emerging applications of bacteriocins. Curr. Opin. Biotechnol. 49, 23-28 (2017).
19. Appleyard, A. N. et al. Dissecting structural and functional diversity of the lantibiotic mersacidin. Chem. Biol. 16, 490-498 (2009).
20. Field, D., O'Connor, P. M., Cotter, P. D., Hill, C. & Ross, R. P. The generation of nisin variants with enhanced activity against specific gram-positive pathogens. Mol. Microbiol. 69, 218-230 (2008).
21. Field, D. et al. Bioengineered nisin a derivatives with enhanced activity against both gram positive and gram negative pathogens. PLoS One 7, e46884 (2012).
22. Rink, R. et al. Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-Terminal truncation. Appl. Environ. Microbiol. 73, 5809-5816 (2007).
23. Rouse, S. et al. Bioengineered nisin derivatives with enhanced activity in complex matrices. Microb. Biotechnol. 5, 501-508 (2012).
24. Islam, M. R. et al. Evaluation of essential and variable residues of nukacin ISK-1 by NNK scanning. Mol. Microbiol. 72, 1438-1447 (2009).
25. Chen, S. et al. Site-directed mutations in the lanthipeptide mutacin 1140. Appl. Environ. Microbiol. 79, 4015-4023 (2013).
26. Rollema, H. S., Kuipers, O. P., Both, P., de Vos, W. M. & Siezen, R. J. Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering. Appl. Environ. Microbiol. 61, 2873-2878 (1995).
27. Yuan, J., Zhang, Z. Z., Chen, X. Z., Yang, W. & Huan, L. D. Site-directed mutagenesis of the hinge region of nisinZ and properties of nisinZ mutants. Appl. Microbiol. Biotechnol. 64, 806-815 (2004).
28. Davison, W. M., Pitts, B. & Stewart, P. S. Spatial and temporal patterns of biocide action against Staphylococcus epidermidis biofilms. Antimicrob. Agents Chemother. 54, 2920-2927 (2010).
29. Field, D., Cotter, P. D., Hill, C. & Ross, R. P. Bioengineering lantibiotics for therapeutic success. Front. Microbiol. 6, 1363 (2015a).
30. Field, D., Cotter, P. D., Ross, R. P. & Hill, C. Bioengineering of the model lantibiotic nisin. Bioengineered 6, 187-192 (2015b).
31. Field, D. et al. A bioengineered nisin derivative to control biofilms of Staphylococcus pseudintermedius. PLoS One 10, e0119684 (2015c).
32. Field, D., O' Connor, R., Cotter, P. D., Ross, R. P. & Hill, C. In vitro activities of nisin and nisin derivatives alone and in combination with antibiotics against Staphylococcus biofilms. Front. Microbiol. 7, 508 (2016a).
33. Castiglione, F. et al. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp. Biochemistry 46, 5884-5895 (2007).
34. Maher, S. & McClean, S. Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro. Biochem. Pharmacol. 71, 1289-1298 (2006).
35. Murinda, S. E., Rashid, K. A. & Roberts, R. F. In vitro assessment of the cytotoxicity of nisin, pediocin, and selected colicins on simian virus 40-Transfected human colon and Vero monkey kidney cells with trypan blue staining viability assays. J. Food Prot. 66, 847-853 (2003).
36. Cox, C. R., Coburn, P. S. & Gilmore, M. S. Enterococcal cytolysin: A novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells. Curr. Protein Pept. Sci. 6, 77-84 (2005).
37. Ando, E., Monden, K., Mitsuhata, R., Kariyama, R. & Kumon, H. Biofilm formation among methicillin-resistant Staphylococcus aureus isolates from patients with urinary tract infection. Acta Med. Okayama. 58, 207-214 (2004).
38. Cha, J. O. et al. Investigation of biofilm formation and its association with the molecular and clinical characteristics of Methicillin-resistant Staphylococcus aureus. Osong. Public Health Res. Perspect. 4, 225-232 (2013).
39. McCarthy, H. et al. Methicillin resistance and the biofilm phenotype in Staphylococcus aureus. Front. Cell. Infect. Microbiol. 5, 1 (2015).
40. Goss, C. H. & Muhlebach, M. S. Staphylococcus aureus and MRSA in cystic fibrosis. J. Cyst. Fibros. 10, 298-306 (2011).
41. Otto, M. Staphylococcal biofilms. Curr. Top. Microbiol. Immunol. 322, 207-228 (2008).
42. Lister, J. L. & Horswill, A. R. Staphylococcus aureus biofilms: recent developments in biofilm dispersal. Front. Cell Infect. Microbiol. 4, 178 (2014).
43. Periasamy, S. et al. How Staphylococcus aureus biofilms develop their characteristic structure. Proc. Natl. Acad. Sci. USA 109, 1281-1286 (2012).
44. Archer, N. K. et al. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2, 445-459 (2011).
45. Dosler, S. & Mataraci, E. In vitro pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms. Peptides 49, 53-58 (2013).
46. Okuda, K. et al. Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm. Antimicrob. Agents Chemother. 57, 5572-5579 (2013).
47. Sashihara, T. et al. A novel lantibiotic, nukacin ISK-1, of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure. Biosci. Biotechnol. Biochem. 64, 2420-2428 (2000).
48. Nishie, M. et al. Lantibiotic transporter requires cooperative functioning of the peptidase domain and the ATP binding domain. J. Biol. Chem. 286, 11163-11169 (2011).
49. Fujita, K. et al. Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria. Appl. Environ. Microbiol. 73, 2871-2877 (2007).
50. Ma, Q., Yu, Z., Han, B., Wang, Q. & Zhang, R. Expression and purification of lacticin Q by small ubiquitin-related modifier fusion in Escherichia coli. J. Microbiol. 50, 326-331 (2012).
51. Pimentel-Filho Nde, J., Martins, M. C., Nogueira, G. B., Mantovani, H. C. & Vanetti, M. C. Bovicin HC5 and nisin reduce Staphylococcus aureus adhesion to polystyrene and change the hydrophobicity profile and Gibbs free energy of adhesion. Int. J. Food Microbiol. 190, 1-8 (2014).
52. Sudagidan, M. & Yemenicioǧlu, A. Effects of nisin and lysozyme on growth inhibition and biofilm formation capacity of Staphylococcus aureus strains isolated from raw milk and cheese samples. J. Food Prot. 75, 1627-1633 (2012).
53. Saising, J. et al. Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms. Antimicrob. Agents Chemother. 56, 5804-5810 (2012).
54. Otto, M. Staphylococcus epidermidis-The 'accidental' pathogen. Nat. Rev. Microbiol. 7, 555-567 (2009).
55. Gomes, F., Teixeira, P. & Oliveira, R. Staphylococcus epidermidis as the most frequent cause of nosocomial infections: old and new fighting strategies. Biofouling 30, 131-141 (2014).
56. Lewis, K. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5, 48-56 (2007).
57. Lewis, K. Persister cells. Annu. Rev. Microbiol. 64, 357-372 (2010).
58. Lewis, K. Persister cells and the riddle of biofilm survival. Biochemistry. (Mosc.). 70, 267-274 (2005).
59. Lewis, K. Multidrug tolerance of biofilms and persister cells. Curr. Top. Microbiol. Immunol. 322, 107-131 (2008).
60. Singh, A., Walker, M., Rousseau, J. & Weese, J. S. Characterization of the biofilm forming ability of Staphylococcus pseudintermedius from dogs. BMC Vet. Res. 9, 93 (2013).
61. Borucki, M. K., Peppin, J. D., White, D., Loge, F. & Call, D. R. Variation in biofilm formation among strains of Listeria monocytogenes. Appl. Environ. Microbiol. 69, 7336-7342 (2003).
62. Houdt, V. & Michiels, C. W. Biofilm formation and the food industry, a focus on the bacterial outer surface. J. Appl. Microbiol. 109, 1117-1131 (2010).
63. Doijad, S. P. et al. Biofilm-forming abilities of Listeria monocytogenes serotypes isolated from different sources. PLoS One 10, e0137046 (2015).
64. Piercey, M. J., Hingston, P. A. & Truelstrup Hansen, L. Genes involved in Listeria monocytogenes biofilm formation at a simulated food processing plant temperature of 15°C. Int. J. Food Microbiol. 223, 63-74 (2016).
65. de Oliveira, M. M., Brugnera, D. F., Alves, E. & Piccoli, R. H. Biofilm formation by Listeria monocytogenes on stainless steel surface and biotransfer potential. Braz. J. Microbiol. 41, 97-106 (2010).
66. Wassinger, A. et al. Role of a GntR-family response regulator LbrA in Listeria monocytogenes biofilm formation. PLoS One 8, e70448 (2013).
67. Møretrø, T. & Langsrud, S. Listeria monocytogenes: Biofilm Formation and Persistence in Food-processing Environments. Biofilms 1, 107-121 (2004).
68. Smith, M. K. et al. A bioengineered nisin derivative, M21A, in combination with food grade additives eradicates biofilms of Listeria monocytogenes. Front. Microbiol. 7, 1939 (2016).
69. Saá Ibusquiza, P., Herrera, J. J. & Cabo, M. L. Resistance to benzalkonium chloride, peracetic acid and nisin during formation of mature biofilms by Listeria monocytogenes. Food Microbiol. 28, 418-425 (2011).
70. Bolocan, A. S. et al. Inhibition of Listeria monocytogenes biofilms by bacteriocin-producing bacteria isolated from mushroom substrate. J. Appl. Microbiol. 122, 279-293 (2017).
71. Mahdavi, M., Jalali, M. & Kermanshahi, R. K. The effect of nisin on biofilm forming foodborne bacteria using microtiter plate method. Res. Pharm. Sci. 2, 113-118 (2007).
72. Gou, J., Jung, L.-S., Lee, S.-H. & Ahn, J. Effects of nisin and acid on the inactivation and recovery of Listeria monocytogenes biofilms treated by high hydrostatic pressure. Food Sci. Biotechnol. 20, 1361-1366 (2011).
73. Field, D., Seisling, N., Cotter, P. D., Ross, R. P. & Hill, C. Synergistic nisin-polymyxin combinations for the control of Pseudomonas biofilm formation. Front. Microbiol. 7, 1713 (2016b).
74. Rasamiravaka, T., Labtani, Q., Duez, P. & El Jaziri, M. The formation of biofilms by Pseudomonas aeruginosa: A review of the natural and synthetic compounds interfering with control mechanisms. Biomed. Res. Int. 2015, 759348 (2015).
75. Sharma, G. et al. Pseudomonas aeruginosa biofilm: potential therapeutic targets. Biologicals 42, 1-7 (2014).
76. Nikaido, H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67, 593-656 (2003).
77. Vaara, M. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56, 395-411 (1992).
78. Morrison, D. C. & Jacobs, D. M. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13, 813-818 (1976).
79. Srimal, S., Surolia, N., Balasubramanian, S. & Surolia, A. Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A. Biochem. J. 315, 679-686 (1996).
80. Hancock, R. E. The bacterial outer membrane as a drug barrier. Trends Microbiol. 5, 37-42 (1997).
81. Giacometti, A., Cirioni, O., Barchiesi, F., Fortuna, M. & Scalise, G. In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa. J. Antimicrob. Chemother. 44, 641-645 (1999).
82. Naghmouchi, K., Drider, D., Baah, J. & Teather, R. Nisin A and Polymyxin B as Synergistic inhibitors of Gram-positive and Gram-negative bacteria. Probiotics Antimicrob. Proteins 2, 98-103 (2010).
83. Naghmouchi, K., Belguesmia, Y., Baah, J., Teather, R. & Drider, D. Antibacterial activity of class I and IIa bacteriocins combined with polymyxin E against resistant variants of Listeria monocytogenes and Escherichia coli. Res. Microbiol. 162, 99-107 (2011).
84. Marsh, P. D. Dental plaque as a biofilm and a microbial community-implications for health and disease. BMC Oral Health 6, S14 (2006).
85. Seneviratne, C. J., Zhang, C. F. & Samaranayake, L. P. Dental plaque biofilm in oral health and disease. Chin. J. Dent. Res. 14, 87-94 (2011).
86. Chandki, R., Banthia, P. & Banthia, R. Biofilms: A microbial home. J. Indian Soc. Periodontol. 15, 111-114 (2011).
87. Zijnge, V. et al. Oral biofilm architecture on natural teeth. PLoS One 5, e9321 (2010).
88. Kolenbrander, P. E., Palmer, R. J. Jr, Periasamy, S. & Jakubovics, N. S. Oral multispecies biofilm development and the key role of cell-cell distance. Nat. Rev. Microbiol. 8, 471-480 (2010).
89. Ahn, S. J., Wen, Z. T., Brady, L. J. & Burne, R. A. Characteristics of biofilm formation by Streptococcus mutans in the presence of saliva. Infect. Immun. 76, 4259-4268 (2008).
90. Stingu, C. S., Eschrich, K., Rodloff, A. C., Schaumann, R. & Jentsch, H. Periodontitis is associated with a loss of colonization by Streptococcus sanguinis. J. Med. Microbiol. 57, 495-499 (2008).
91. Ogawa, A. et al. Inhibition of Streptococcus mutans biofilm formation by Streptococcus salivarius FruA. Appl. Environ. Microbiol. 77, 1572-1580 (2011).
92. Decker, E. M., Klein, C., Schwindt, D. & von Ohle, C. Metabolic activity of Streptococcus mutans biofilms and gene expression during exposure to xylitol and sucrose. Int. J. Oral Sci. 6, 195-204 (2014).
93. Kunze, B. et al. Damage of Streptococcus mutans biofilms by carolacton, a secondary metabolite from the myxobacterium Sorangium cellulosum. BMC Microbiol. 10, 199 (2010).
94. Clark, S. A., Vinson, L. A., Eckert, G. & Gregory, R. L. Effect of commonly prescribed liquid medications on Streptococcus mutans biofilm. An in vitro study. J. Clin. Pediatr. Dent. 41, 141-146 (2017).
95. Tong, Z. et al. An in vitro study on the effect of free amino acids alone or in combination with nisin on biofilms as well as on planktonic bacteria of Streptococcus mutans. PLoS One 9, e99513 (2014).
96. Yamakami, K. et al. Sustainable inhibition efficacy of liposome-encapsulated nisin on insoluble glucan-biofilm synthesis by Streptococcus mutans. Pharm. Biol. 51, 267-270 (2013).
97. Corbin, A., Pitts, B., Parker, A. & Stewart, P. S. Antimicrobial penetration and efficacy in an in vitro oral biofilm model. Antimicrob. Agents Chemother. 55, 3338-3344 (2011).
98. Dobson, A., O'Connor, P. M., Cotter, P. D., Ross, R. P. & Hill, C. Impact of the broad-spectrum antimicrobial peptide, lacticin 3147, on Streptococcus mutans growing in a biofilm and in human saliva. J. Appl. Microbiol. 111, 1515-1523 (2011).
99. Tong, Z., Ling, J., Lin, Z., Li, X. & Mu, Y. The effect of MTADN on 10 Enterococcus faecalis isolates and biofilm: An in vitro study. J. Endod. 39, 674-678 (2013).
100. Barnes, A. M., Ballering, K. S., Leibman, R. S., Wells, C. L. & Dunny, G. M. Enterococcus faecalis produces abundant extracellular structures containing DNA in the absence of cell lysis during early biofilm formation. mBio 3, e00193-00112 (2012).
101. Mohamed, J. A. & Huang, D. B. Biofilm formation by enterococci. J. Med. Microbiol. 56, 1581-1588 (2007).
102. Kristich, C. J., Li, Y. H., Cvitkovitch, D. G. & Dunny, G. M. Esp-independent biofilm formation by Enterococcus faecalis. J. Bacteriol. 186, 154-163 (2004).
103. Duggan, J. M. & Sedgley, C. M. Biofilm formation of oral and endodontic Enterococcus faecalis. J. Endod. 33, 815-818 (2007).
104. Kajwadkar, R. et al. High-purity nisin alone or in combination with sodium hypochlorite is effective against planktonic and biofilm populations of Enterococcus faecalis. J. Endod. 43, 989-994 (2017).
105. Dige, I., Raarup, M. K., Nyengaard, J. R., Kilian, M. & Nyvad, B. Actinomyces naeslundii in initial dental biofilm formation. Microbiology 155, 2116-2126 (2009).
106. Li, J. et al. Identification of early microbial colonizers in human dental biofilm. J. Appl. Microbiol. 97, 1311-1318 (2004).
107. Huang, R., Li, M. & Gregory, R. L. Bacterial interactions in dental biofilm. Virulence 2, 435-444 (2011).
108. Mardis, J. S. & Many, W. J. Jr. Endocarditis due to Actinomyces viscosus. South Med. J. 94, 240-243 (2001).
109. Balto, H. A., Shakoor, Z. A. & Kanfar, M. A. Combined effect of a mixture of tetracycline, acid, and detergent, and nisin against Enterococcus faecalis and Actinomyces viscosus biofilms. Saudi. Med. J. 36, 211-215 (2015).
110. Graham, C. E., Cruz, M. R., Garsin, D. A. & Lorenz, M. C. Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans. Proc. Natl. Acad. Sci. USA 114, 4507-4512 (2017).
111. Singh, A., Verma, R., Murari, A. SpringerAmpamp; Agrawal, A. Oral candidiasis: An overview. J. Oral Maxillofac. Pathol. 18, S81-S85 (2014).
112. Achkar, J. M. & Fries, B. C. Candida infections of the genitourinary tract. Clin. Microbiol. Rev. 23, 253-273 (2010).
113. Chopra, L., Singh, G., Kumar Jena, K. & Sahoo, D. K. Sonorensin: A new bacteriocin with potential of an anti-biofilm agent and a food biopreservative. Sci. Rep. 5, 13412 (2015).
114. Chopra, L., Singh, G., Choudhary, V. & Sahoo, D. K. Sonorensin: An antimicrobial peptide, belonging to the heterocycloanthracin subfamily of bacteriocins, from a new marine isolate, Bacillus sonorensis MT93. Appl. Environ. Microbiol. 80, 2981-2990 (2014).
115. Caballero Gómez, N., Abriouel, H., Grande, M. J., Pérez Pulido, R. & Gálvez, A. Combined treatments of enterocin AS-48 with biocides to improve the inactivation of methicillin-sensitive and methicillin-resistant Staphylococcus aureus planktonic and sessile cells. Int. J. Food Microbiol. 163, 96-100 (2013a).
116. Cebrián, R. et al. Analysis of the promoters involved in enterocin AS-48 expression. PLoS One 9, e90603 (2014).
117. Grande Burgos, M. J., Pulido, R. P., Del Carmen López Aguayo, M., Gálvez, A. & Lucas, R. The cyclic antibacterial peptide enterocin AS-48: isolation, mode of action, and possible food applications. Int. J. Mol. Sci. 15, 22706-22727 (2014).
118. Al-Atya, A. K. et al. Anti-MRSA activities of enterocins DD28 and DD93 and evidences on their role in the inhibition of biofilm formation. Front. Microbiol. 7, 817 (2016a).
119. Duarte, A. F. S. et al. Hyicin 4244, the first sactibiotic described in staphylococci, exhibits an anti-staphylococcal biofilm activity. Int. J. Antimicrob. Agents. https://doi.org/10.1016/j.ijantimicag.2017.06.025 (2017).
120. Caballero Gómez, N., Abriouel, H., Ennahar, S. & Gálvez, A. Comparative proteomic analysis of Listeria monocytogenes exposed to enterocin AS-48 in planktonic and sessile states. Int. J. Food Microbiol. 167, 202-207 (2013b).
121. Gómez, N. C., Abriouel, H., Grande, M. A., Pulido, R. P. & Gálvez, A. Effect of enterocin AS-48 in combination with biocides on planktonic and sessile Listeria monocytogenes. Food Microbiol. 30, 51-58 (2012).
122. Cirkovic, I. et al. Licheniocin 50.2 and bacteriocins from Lactococcus lactis subsp. lactis biovar. diacetylactis BGBU1-4 inhibit biofilms of coagulase negative staphylococci and Listeria monocytogenes clinical isolates. PLoS One 11, e0167995 (2016).
123. Becker, K., Heilmann, C. & Peters, G. Coagulase-negative staphylococci. Clin. Microbiol. Rev. 27, 870-926 (2014).
124. Mack, D., Haeder, M., Siemssen, N. & Laufs, R. Association of biofilm production of coagulase-negative staphylococci with expression of a specific polysaccharide intercellular adhesin. J. Infect. Dis. 174, 881-884 (1996).
125. Tremblay, Y. D., Caron, V., Blondeau, A., Messier, S. & Jacques, M. Biofilm formation by coagulase-negative staphylococci: impact on the efficacy of antimicrobials and disinfectants commonly used on dairy farms. Vet. Microbiol. 172, 511-518 (2014).
126. Oliveira, A. & Cunha, M. L. R. S. Bacterial biofilms with emphasis on coagulase-negative staphylococci. J. Venom. Anim. Toxins Incl. Trop. Dis. 14, 572-596 (2008).
127. Al-Atya, A. K. et al. Effects of colistin and bacteriocins combinations on the in vitro growth of Escherichia coli strains from swine origin. Probiotics Antimicrob. Proteins 8, 183-190 (2016b).
128. Caly, D. L. et al. The safe enterocin DD14 is a leaderless two-peptide bacteriocin with anti-Clostridium perfringens activity. Int. J. Antimicrob. Agents 49, 282-289 (2017).
129. Ntsama-Essomba, C., Bouttier, S., Ramaldes, M., Dubois-Brissonnet, F. & Fourniat, J. Resistance of Escherichia coli growing as biofilms to disinfectants. Vet. Res. 28, 353-363 (1997).
130. Turovskiy, Y. et al. Susceptibility of Gardnerella vaginalis biofilms to natural antimicrobials subtilosin, ϵ-poly-L-lysine, and lauramide arginine ethyl ester. Dis. Obstet. Gynecol. 2012, 284762 (2012).
131. Patterson, J. L., Girerd, P. H., Karjane, N. W. & Jefferson, K. K. Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am. J. Obstet. Gynecol. 197, 170.e1-7 (2007).
132. Patterson, J. L., Stull-Lane, A., Girerd, P. H. & Jefferson, K. K. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-Associated anaerobes. Microbiology 156, 392-399 (2010).
133. Algburi, A. et al. Subtilosin prevents biofilm formation by inhibiting bacterial quorum sensing. Probiotics Antimicrob. Proteins 9, 81-90 (2017).
134. Calasso, M. et al. Effects of the peptide pheromone plantaricin A and cocultivation with Lactobacillus sanfranciscensis DPPMA174 on the exoproteome and the adhesion capacity of Lactobacillus plantarum DC400. Appl. Environ. Microbiol. 79, 2657-2669 (2013).
135. Al-Seraih, A. et al. Enterocin B3A-B3B produced by LAB collected from infant faeces: potential utilization in the food industry for Listeria monocytogenes biofilm management. Antonie Van Leeuwenhoek 110, 205-219 (2017).
136. Nostro, A. et al. Control of biofilm formation by poly-ethylene-co-vinyl acetate films incorporating nisin. Appl. Microbiol. Biotechnol. 87, 729-737 (2010).
137. Qi, X. et al. Covalent immobilization of nisin on multi-walled carbon nanotubes: superior antimicrobial and anti-biofilm properties. Nanoscale 3, 1874-1880 (2011).
138. Dong, X., McCoy, E., Zhang, M. & Yang, L. Inhibitory effects of nisin-coated multi-walled carbon nanotube sheet on biofilm formation from Bacillus anthracisspores. J. Environ. Sci. (China) 26, 2526-2534 (2014).
139. Lee, K. et al. Phenotypic and functional characterization of Bacillus anthracis biofilms. Microbiology 153, 1693-1701 (2007).
140. Ahire, J. J. & Dicks, L. M. Nisin incorporated with 2,3-dihydroxybenzoic acid in nanofibers inhibits biofilm formation by a methicillin-resistant strain of Staphylococcus aureus. Probiotics. Antimicrob. Proteins 7, 52-59 (2015).
141. Héquet, A., Humblot, V., Berjeaud, J. M. & Pradier, C. M. Optimized grafting of antimicrobial peptides on stainless steel surface and biofilm resistance tests. Colloids Surf. B Biointerfaces 84, 301-309 (2011).
142. Ming, L., Zhang, Q., Yang, L. & Huang, J. A. Comparison of antibacterial effects between antimicrobial peptide and bacteriocins isolated from Lactobacillus plantarum on three common pathogenic bacteria. Int. J. Clin. Exp. Med. 8, 5806-5811 (2015).
143. Shanks, R. M., Dashiff, A., Alster, J. S. & Kadouri, D. E. Isolation and identification of a bacteriocin with antibacterial and antibiofilm activity from Citrobacter freundii. Arch. Microbiol. 194, 575-587 (2012).
144. Vuotto, C., Longo, F., Balice, M. P., Donelli, G. & Varaldo, P. E. Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae. Pathogens 3, 743-758 (2014).
145. Stahlhut, S. G., Struve, C., Krogfelt, K. A. & Reisner, A. Biofilm formation of Klebsiella pneumoniae on urethral catheters requires either type 1 or type 3 fimbriae. Fems. Immunol. Med. Microbiol. 65, 350-359 (2012).
146. Vahedi Shahandashti, R., Kasra Kermanshahi, R. & Ghadam, P. The inhibitory effect of bacteriocin produced by Lactobacillus acidophilus ATCC 4356 and Lactobacillus plantarum ATCC 8014 on planktonic cells and biofilms of Serratia marcescens. Turk. J. Med. Sci. 46, 1188-1196 (2016).
147. Greco-Stewart, V. S. et al. Serratia marcescens strains implicated in adverse transfusion reactions form biofilms in platelet concentrates and demonstrate reduced detection by automated culture. Vox. Sang. 102, 212-220 (2012).
148. Bakkiyaraj, D., Sivasankar, C. & Pandian, S. K. Inhibition of quorum sensing regulated biofilm formation in Serratia marcescens causing nosocomial infections. Bioorg. Med. Chem. Lett. 22, 3089-3094 (2012).
149. Pérez-Ibarreche, M., Castellano, P., Leclercq, A. & Vignolo, G. Control of Listeria monocytogenes biofilms on industrial surfaces by the bacteriocin-producing Lactobacillus sakei CRL1862. FEMS Microbiol. Lett. https://doi.org/10.1093/femsle/fnw118 (2016).
150. Minei, C. C., Gomes, B. C., Ratti, R. P., D'Angelis, C. E. & De Martinis, E. C. Influence of peroxyacetic acid and nisin and coculture with Enterococcus faecium on Listeria monocytogenes biofilm formation. J. Food Prot. 71, 634-638 (2008).
151. Camargo, A. C., de Paula, O. A., Todorov, S. D. & Nero, L. A. In vitro evaluation of bacteriocins activity against Listeria monocytogenes biofilm formation. Appl. Biochem. Biotechnol. 178, 1239-1251 (2016).
152. Rybalchenko, O. V., Bondarenko, V. M., Orlova, O. G., Markov, A. G. & Amasheh, S. Inhibitory effects of Lactobacillus fermentum on microbial growth and biofilm formation. Arch. Microbiol. 197, 1027-1032 (2015).
153. Chandra, J. et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183, 5385-5394 (2001).
154. Pierce, C. G. et al. A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance. NPJ Biofilms Micro. 1, 15012 (2015).
155. Lin, X., Chen, X., Chen, Y., Jiang, W. & Chen, H. The effect of five probiotic lactobacilli strains on the growth and biofilm formation of Streptococcus mutans. Oral Dis. 21, e128-e134 (2015).
156. Boakes, S. & Dawson, M. J. Discovery and development of NVB302, a semisynthetic antibiotic for treatment of Clostridium difficile infection. in Natural Products: Discourse, Diversity, and Design 1st edn, Vol. 1 (eds Osbourn, A., Goss, R. J. & Carter, G. T.) Ch. 24 (John Wiley & Sons, 2014).
157. Dawson, M. J. & Scott, R. W. New horizons for host defense peptides and lantibiotics. Curr. Opin. Pharmacol. 12, 545-550 (2012).
158. Corr, S. C. et al. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. USA 104, 7617-7621 (2007).
159. O'Callaghan, J., Buttó, L. F., MacSharry, J., Nally, K. & O'Toole, P. W. Influence of adhesion and bacteriocin production by Lactobacillus salivarius on the intestinal epithelial cell transcriptional response. Appl. Environ. Microbiol. 78, 5196-5203 (2012).
160. Gillor, O., Giladi, I. & Riley, M. A. Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract. BMC Microbiol. 9, 165 (2009).
161. Hegarty, J. W., Guinane, C. M., Ross, R. P., Hill, C. & Cotter, P. D. Bacteriocin production: A relatively unharnessed probiotic trait? F1000Res. 5, 2587 (2016).
162. Dobson, A., Cotter, P. D., Ross, R. P. & Hill, C. Bacteriocin production: A probiotic trait? Appl. Environ. Microbiol. 78, 1-6 (2012).
163. Azeredo, J. et al. Critical review on biofilm methods. Crit. Rev. Microbiol. 43, 313-351 (2017).
164. Abdelraouf, K. et al. Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design. Antimicrob. Agents Chemother. 56, 4625-4629 (2012).
165. Gullberg, E. et al. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 7, e1002158 (2011).
166. Sandegren, L. Selection of antibiotic resistance at very low antibiotic concentrations. Ups. J. Med. Sci. 119, 103-107 (2014).
167. Martínez, J. L. Antibiotics and antibiotic resistance genes in natural environments. Science 321, 365-367 (2008).
168. Ohlsen, K. et al. Effects of subinhibitory concentrations of antibiotics on alpha-Toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 42, 2817-2823 (1998).
169. Ołdak, E. & Trafny, E. A. Secretion of proteases by Pseudomonas aeruginosa biofilms xposed to ciprofloxacin. Antimicrob. Agents Chemother. 49, 3281-3288 (2005).
170. Takahashi, N. & Nyvad, B. The role of bacteria in the caries process: ecological perspectives. J. Dent. Res. 90, 294-303 (2011).
171. Kleinberg, I. A mixed-bacteria ecological approach to understanding the role of the oral bacteria in dental caries causation: An alternative to Streptococcus mutans and the specific-plaque hypothesis. Crit. Rev. Oral Biol. Med. 13, 108-125 (2002).
172. Hale, J. D., Ting, Y. T., Jack, R. W., Tagg, J. R. & Heng, N. C. Bacteriocin (mutacin) production by Streptococcus mutans genome sequence reference strain UA159: elucidation of the antimicrobial repertoire by genetic dissection. Appl. Environ. Microbiol. 71, 7613-7617 (2005).
173. Kreth, J., Merritt, J., Bordador, C., Shi, W. & Qi, F. Transcriptional analysis of mutacin I (mutA) gene expression in planktonic and biofilm cells of Streptococcus mutans using fluorescent protein and glucuronidase reporters. Oral. Microbiol. Immunol. 19, 252-256 (2004).
174. Kreth, J., Zhang, Y. & Herzberg, M. C. Streptococcal antagonism in oral biofilms: Streptococcus sanguinis and Streptococcus gordonii interference with Streptococcus mutans. J. Bacteriol. 190, 4632-4640 (2008).
175. Buommino, E., Scognamiglio, M., Donnarumma, G., Fiorentino, A. & D'Abrosca, B. Recent advances in natural product-based anti-biofilm approaches to control infections. Mini. Rev. Med. Chem. 14, 1169-1182 (2014).
176. Brackman, G. & Coenye, T. Quorum sensing inhibitors as anti-biofilm agents. Curr. Pharm. Des. 21, 5-11 (2015).